{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:08:36Z","timestamp":1792955316156,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Daiichi Sankyo, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40801-025-00496-9","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:04:24Z","timestamp":1748642664000},"page":"213-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Intravenous Iron Replacement Therapy on Healthcare Costs for Patients with Iron Deficiency Anemia in the USA: A Retrospective Analysis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1359-3530","authenticated-orcid":false,"given":"Nicole M.","family":"Engel-Nitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winghan Jacqueline","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"12","key":"496_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jama.1997.03540360041028","volume":"277","author":"AC Looker","year":"1997","unstructured":"Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;277(12):973\u20136. https:\/\/doi.org\/10.1001\/jama.1997.03540360041028.","journal-title":"JAMA"},{"issue":"1","key":"496_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2021-000759","volume":"9","author":"A Kumar","year":"2022","unstructured":"Kumar A, Sharma E, Marley A, Samaan MA, Brookes MJ. Iron deficiency anaemia: pathophysiology, assessment, practical management. BMJ Open Gastroenterol. 2022;9(1): e000759. https:\/\/doi.org\/10.1136\/bmjgast-2021-000759.","journal-title":"BMJ Open Gastroenterol"},{"issue":"7","key":"496_CR3","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/annonc\/mdt118","volume":"24","author":"H Ludwig","year":"2013","unstructured":"Ludwig H, M\u00fcld\u00fcr E, Endler G, H\u00fcbl W. Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia. Ann Oncol. 2013;24(7):1886\u201392. https:\/\/doi.org\/10.1093\/annonc\/mdt118.","journal-title":"Ann Oncol"},{"issue":"18","key":"496_CR4","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/cir.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895-1032. https:\/\/doi.org\/10.1161\/cir.0000000000001063.","journal-title":"Circulation"},{"issue":"1","key":"496_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2215\/cjn.01670408","volume":"4","author":"S Fishbane","year":"2009","unstructured":"Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004. Clin J Am Soc Nephrol. 2009;4(1):57\u201361. https:\/\/doi.org\/10.2215\/cjn.01670408.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"496_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/joim.13004","volume":"287","author":"MD Cappellini","year":"2020","unstructured":"Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020;287(2):153\u201370. https:\/\/doi.org\/10.1111\/joim.13004.","journal-title":"J Intern Med"},{"key":"496_CR7","unstructured":"Patnaik MM. Role of ESAs in adults with non-hematologic cancers. UpToDate. https:\/\/www.uptodate.com\/contents\/role-of-esas-in-adults-with-non-hematologic-cancers?search=role%20of%20esas&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1. Accessed 13 Mar 2024."},{"key":"496_CR8","unstructured":"Auerbach M, DeLoughery TG. Causes and diagnosis of iron deficiency and iron deficiency anemia in adults. UpToDate. https:\/\/www.uptodate.com\/contents\/causes-and-diagnosis-of-iron-deficiency-and-iron-deficiency-anemia-in-adults?topicRef=2799&source=see_link#H747006870. Accessed 13 Mar 2024."},{"issue":"4","key":"496_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12254-023-00902-4","volume":"16","author":"R Heregger","year":"2023","unstructured":"Heregger R, Greil R. Erythropoiesis-stimulating agents: benefits and harms in the treatment of anemia in cancer patients. MEMO Mag Eur Med Oncol. 2023;16(4):259\u201362. https:\/\/doi.org\/10.1007\/s12254-023-00902-4.","journal-title":"MEMO Mag Eur Med Oncol."},{"issue":"Suppl. 4","key":"496_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/annonc\/mdx758","volume":"29","author":"M Aapro","year":"2018","unstructured":"Aapro M, Beguin Y, Bokemeyer C, et al. Management of anaemia and iron deficiency in patients with cancer: ESMO clinical practice guidelines. Ann Oncol. 2018;29(Suppl. 4):96\u2013110. https:\/\/doi.org\/10.1093\/annonc\/mdx758.","journal-title":"Ann Oncol"},{"key":"496_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","volume":"205","author":"N Ebner","year":"2016","unstructured":"Ebner N, Jankowska EA, Ponikowski P, et al. The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure. Int J Cardiol. 2016;205:6\u201312. https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.178.","journal-title":"Int J Cardiol"},{"issue":"5","key":"496_CR12","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/01635581.2019.1658794","volume":"72","author":"B Abiri","year":"2020","unstructured":"Abiri B, Vafa M. Iron deficiency and anemia in cancer patients: the role of iron treatment in anemic cancer patients. Nutr Cancer. 2020;72(5):864\u201372. https:\/\/doi.org\/10.1080\/01635581.2019.1658794.","journal-title":"Nutr Cancer"},{"issue":"5","key":"496_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.ajkd.2013.06.008","volume":"62","author":"AS Kliger","year":"2013","unstructured":"Kliger AS, Foley RN, Goldfarb DS, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD. Am J Kidney Dis. 2013;62(5):849\u201359. https:\/\/doi.org\/10.1053\/j.ajkd.2013.06.008.","journal-title":"Am J Kidney Dis"},{"key":"496_CR14","unstructured":"Injectafer. Prescribing information. Daichi Sankyo; 2023. https:\/\/daiichisankyo.us\/prescribing-information-portlet\/getDocument?product=IF&inline=true. Accessed 13 Mar 2024."},{"key":"496_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100862","volume":"75","author":"B Schaefer","year":"2020","unstructured":"Schaefer B, Meindl E, Wagner S, Tilg H, Zoller H. Intravenous iron supplementation therapy. Mol Aspects Med. 2020;75: 100862. https:\/\/doi.org\/10.1016\/j.mam.2020.100862.","journal-title":"Mol Aspects Med"},{"key":"496_CR16","unstructured":"Venofer. Prescribing information. American Regent, Inc.; 2022. https:\/\/www.venofer.com\/pdfs\/venofer-prescribing-information.pdf. Accessed 13 Mar 2024."},{"key":"496_CR17","unstructured":"INFeD. Prescribing information. Allergan USA; 2021. https:\/\/www.rxabbvie.com\/pdf\/infed_pi.pdf. Accessed 13 Mar 2024."},{"key":"496_CR18","unstructured":"Ferrlecit. Prescribing information. Sanofi-Aventis US; 2022. https:\/\/products.sanofi.us\/ferrlecit\/ferrlecit.pdf. Accessed 13 Mar 2024."},{"issue":"23","key":"496_CR19","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1182\/bloodadvances.2024013197","volume":"8","author":"JC Cogan","year":"2024","unstructured":"Cogan JC, Meyer J, Jiang Z, Sholzberg M. Iron deficiency resolution and time to resolution in an American health system. Blood Adv. 2024;8(23):6029\u201334. https:\/\/doi.org\/10.1182\/bloodadvances.2024013197.","journal-title":"Blood Adv"},{"issue":"4","key":"496_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","volume":"79","author":"G Masini","year":"2022","unstructured":"Masini G, Graham FJ, Pellicori P, et al. Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol. 2022;79(4):341\u201351. https:\/\/doi.org\/10.1016\/j.jacc.2021.11.039.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"496_CR21","doi-asserted-by":"publisher","first-page":"i16","DOI":"10.1093\/ckj\/sfx043","volume":"10","author":"IC Macdougall","year":"2017","unstructured":"Macdougall IC. Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions. Clin Kidney J. 2017;10(Suppl. 1):i16-24. https:\/\/doi.org\/10.1093\/ckj\/sfx043.","journal-title":"Clin Kidney J"},{"issue":"25","key":"496_CR22","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361(25):2436\u201348. https:\/\/doi.org\/10.1056\/NEJMoa0908355.","journal-title":"N Engl J Med"},{"issue":"4","key":"496_CR23","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","volume":"168","author":"L Beck-da-Silva","year":"2013","unstructured":"Beck-da-Silva L, Piardi D, Soder S, et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. Int J Cardiol. 2013;168(4):3439\u201342. https:\/\/doi.org\/10.1016\/j.ijcard.2013.04.181.","journal-title":"Int J Cardiol"},{"issue":"11","key":"496_CR24","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/ndt\/gfu201","volume":"29","author":"IC Macdougall","year":"2014","unstructured":"Macdougall IC, Bock AH, Carrera F, et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014;29(11):2075\u201384. https:\/\/doi.org\/10.1093\/ndt\/gfu201.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"496_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657\u201368. https:\/\/doi.org\/10.1093\/eurheartj\/ehu385.","journal-title":"Eur Heart J"},{"issue":"1","key":"496_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ejhf.823","volume":"20","author":"SD Anker","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ, et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20(1):125\u201333. https:\/\/doi.org\/10.1002\/ejhf.823.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"496_CR27","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/s2352-3026(22)00402-1","volume":"10","author":"K Talboom","year":"2023","unstructured":"Talboom K, Borstlap WAA, Roodbeen SX, et al. Ferric carboxymaltose infusion versus oral iron supplementation for preoperative iron deficiency anaemia in patients with colorectal cancer (FIT): a multicentre, open-label, randomised, controlled trial. Lancet Haematol. 2023;10(4):e250\u201360. https:\/\/doi.org\/10.1016\/s2352-3026(22)00402-1.","journal-title":"Lancet Haematol."},{"issue":"2","key":"496_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s40801-024-00418-1","volume":"11","author":"WJ Kwong","year":"2024","unstructured":"Kwong WJ, Wang K, Wang P, Boccia R. Effect of ferric carboxymaltose versus low-dose intravenous iron therapy and iron sucrose on the total cost of care in patients with iron deficiency anemia: a US claims database analysis. Drugs Real World Outcomes. 2024;11(2):251\u201361. https:\/\/doi.org\/10.1007\/s40801-024-00418-1.","journal-title":"Drugs Real World Outcomes."},{"issue":"1","key":"496_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s13104-021-05875-3","volume":"14","author":"P Diaba-Nuhoho","year":"2021","unstructured":"Diaba-Nuhoho P, Amponsah-Offeh M. Reproducibility and research integrity: the role of scientists and institutions. BMC Res Notes. 2021;14(1):451. https:\/\/doi.org\/10.1186\/s13104-021-05875-3.","journal-title":"BMC Res Notes"},{"key":"496_CR30","unstructured":"Consumer Price Index. Medical care. Series ID: CUUR0000SAM. US Department of Labor, Bureau of Labor Statistics. Washington, DC."},{"key":"496_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev.publhealth.20.1.125","volume":"20","author":"P Diehr","year":"1999","unstructured":"Diehr P, Yanez D, Ash A, Hornbrook M, Lin DY. Methods for analyzing health care utilization and costs. Annu Rev Public Health. 1999;20:125\u201344. https:\/\/doi.org\/10.1146\/annurev.publhealth.20.1.125.","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"496_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0167-6296(98)00025-3\/","volume":"17","author":"WG Manning","year":"1998","unstructured":"Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17(3):283\u201395. https:\/\/doi.org\/10.1016\/s0167-6296(98)00025-3\/.","journal-title":"J Health Econ"},{"issue":"4","key":"496_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0167-6296(01)00086-8","volume":"20","author":"WG Manning","year":"2001","unstructured":"Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461\u201394. https:\/\/doi.org\/10.1016\/s0167-6296(01)00086-8.","journal-title":"J Health Econ"},{"issue":"3","key":"496_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40273-023-01319-x","volume":"42","author":"J Zhou","year":"2024","unstructured":"Zhou J, Williams C, Keng MJ, Wu R, Mihaylova B. Estimating costs associated with disease model states using generalized linear models: a tutorial. Pharmacoeconomics. 2024;42(3):261\u201373. https:\/\/doi.org\/10.1007\/s40273-023-01319-x.","journal-title":"Pharmacoeconomics"},{"key":"496_CR35","unstructured":"National Cancer Institute Division of Cancer Control and Population Sciences. NCI comorbidity index overview. Updated 4\/19\/2024. https:\/\/healthcaredelivery.cancer.gov\/seermedicare\/considerations\/comorbidity.html. Accessed 19 May 2025."},{"issue":"6","key":"496_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq4334","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382. https:\/\/doi.org\/10.1093\/aje\/kwq4334.","journal-title":"Am J Epidemiol"},{"key":"496_CR37","unstructured":"Ferric carboxymaltose. REDBOOK. Merative Micromedex. Merative. Ann Arbor, MI. 2023. http:\/\/www.micromedexsolutions.com. Accessed 19 May 2025."},{"key":"496_CR38","unstructured":"Iron sucrose. RED BOOK. Merative Micromedex. Merative. Ann Arbor, MI. 2023. http:\/\/www.micromedexsolutions.com. Accessed 19 May 2025."},{"key":"496_CR39","unstructured":"Iron dextran. RED BOOK. Merative Micromedex. Merative. Ann Arbor, MI. 2023. http:\/\/www.micromedexsolutions.com. Accessed 19 May 2025."},{"key":"496_CR40","unstructured":"Ferric gluconate. RED BOOK. Merative Micromedex. Merative. Ann Arbor, MI. 2023. http:\/\/www.micromedexsolutions.com. Accessed 19 May 2025."},{"issue":"9","key":"496_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10198-013-0533-9","volume":"15","author":"E Brock","year":"2014","unstructured":"Brock E, Braunhofer P, Troxler J, Schneider H. Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data. Eur J Health Econ. 2014;15(9):907\u201316. https:\/\/doi.org\/10.1007\/s10198-013-0533-9.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"496_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/thc-151074","volume":"24","author":"X Calvet","year":"2016","unstructured":"Calvet X, Gen\u00e9 E, \u00c0ngelRu\u00edz M, et al. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technol Health Care. 2016;24(1):111\u201320. https:\/\/doi.org\/10.3233\/thc-151074.","journal-title":"Technol Health Care"},{"issue":"8","key":"496_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255104","volume":"16","author":"A Basha","year":"2021","unstructured":"Basha A, Ibrahim MIM, Hamad A, et al. Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia. PLoS ONE. 2021;16(8): e0255104. https:\/\/doi.org\/10.1371\/journal.pone.0255104.","journal-title":"PLoS ONE"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00496-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-025-00496-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00496-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:02:11Z","timestamp":1750172531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-025-00496-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1007\/s40801-025-00496-9","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"4 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Optum Life Sciences was contracted by Daiichi Sankyo, Inc. to conduct this analysis. The analysis was funded by Daichi Sankyo, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Nicole M. Engel-Nitz is an employee of Optum Life Sciences and a shareholder in UnitedHealth Group. Amy Anderson and Summer Tran were employees of Optum Life Sciences at the time the analysis was conducted, and Amy Anderson is a shareholder in UnitedHealth Group. Kevin Wang is an employee of Daiichi Sankyo and Winghan Jacqueline Kwong was an employee of Daiichi Sankyo at the time this analysis was conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Institutional review board approval or a waiver of approval was not required for this study because the study data were secondary and de-identified in accordance with the United States Department of Health and Human Services Privacy Rule\u2019s requirements for de-identification codified at 45 C.F.R. \u00a7 164.514(b).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data contained in the database used for the study contain proprietary elements owned by Optum and, therefore, cannot be broadly disclosed or made publicly available at this time. The disclosure of these data to third parties assumes certain data security and privacy protocols are in place and that the third party has executed a standard license agreement, which includes restrictive covenants governing the use of the data.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"All named authors meet the International Committee of Medical Journal Editors criteria for authorship for this article, take responsibility for the integrity of the work as a whole, contributed to the writing and reviewing of the manuscript, and have given final approval of the version to be published. NMEN, WJK, ST, and KW were involved in the conception and design of the study and data interpretation. NMEN and AA were involved in the acquisition of data. NMEN, ST, and AA were involved in the data analysis. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}